New patent for Benuvia drug SYNDROS

Annual Drug Patent Expirations for SYNDROS Syndros is a drug marketed by Benuvia and is included in one NDA. There are three patents protecting this drug and two Paragraph IV…

The post New patent for Benuvia drug SYNDROS appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog